[1]
Lee, S.H.; Lee, W.; Bae, J.S.; Ma, E. Synthesis and in vitro and in vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides. Molecules, 2016, 21(5), 676.
[2]
Mackman, N. Triggers, targets and treatments for thrombosis. Nature, 2008, 451(7181), 914-918.
[3]
Tian, Z. Clinical study on antiplatelet aggregation of picotamide. . Thesis, Jilin University: China, 2004.
[4]
Li, X. Structure Design and Synthesis of 4-ethoxy-1,3-
Benzenedisulfonamide Derivatives and Anti-platelet Aggregation
Activity in vitro., Thesis, Tianjin University: China,. 2016.
[5]
Liu, X.J.; Zhang, F.X.; Zhang, L.G.; Zhang, J.; Li, G.Z.; Wang, B.J.; Shao, Y.L.; Fang, L.; Cheng, M.S. Synthesis of the derivatives of picotamide and the inhibition of blood platelet aggregation. Chin. J. Med. Chem. , 2005, 15(6), 332-335.
[6]
Liu, X.J.; Shao, Y.L.; Wang, C.Q.; He, X.; Si, H.Q.; Wang, S.J. Synthesis of picotamide analogues and their platelet aggregation inhibitory activities. Chin. J. Med. Chem., 2007, 17(6), 354-357.
[7]
Zhao, D.Y.; Meng, J.; Wang, T.T.; Deng, N.; Liu, X.J. Synthesis and in vitro anti-platelet aggregation activity of 4-methoxy-1,3-benzenediolate compounds. J. China Pharm. Univ., 2012, 43(1), 21-24.
[8]
Wang, T.T.; Liu, X.J.; Shao, Y.L.; Si, H.Q.; Hu, T.; Zhang, J.; Shi, X.X. Synthesis and in vitro activities on anti-platelet aggregation of N,N′-di(2-substituted-phenyl)-4-methoxybenzene-1,3- disulfonamides. Chin. J. Med. Chem., 2012, 2, 99-103.
[9]
Lin, Y.B.; Li, X.; Shi, T.E.; Li, G.L.; Liu, X.J. Synthesis and antiplatelet aggregation activity of 4-ethoxy-N, N′- di(substituted phenyl)amides. Chin. J. Med. Chem., 2015, 5, 355-360.
[10]
Deng, Q.S.; Zhang, Q.X.; Wang, C.Q.; Liu, X.J. Synthesis and in vitro antiplatelet aggregation activity of N1,N3-dibenzyl-4-methoxy-1,3-benzenedisulfonamide compounds. Chin. J. Med. Chem., 2017, 5, 355-359.
[11]
Zhao, H.; Chu, Q.Q.; Wang, H.; Shang, Z.H. Synthetic process of Betrixaban. Chin. J. New Drugs, 2014, 24, 2902-2904.
[12]
Hu, T.T.; Zhu, H.; Lin, M.Q.; Song, H.T. Research progress of novel oral anticoagulants in the treatment of non-valvular atrial fibrillation. China Pharm., 2016, 27(8), 1139-1142.
[13]
Wang, D.; Zhang, J.M. Research advances in the prevention of atrial fibrillation-related stroke with novel oral anticoagulants. J. Pract. Cardiol. Brain Pulmon. Dis., 2015, 8, 1-4.
[14]
Zhang, J.Z. An overview of new drugs approved by the FDA in June 2017. Sh. Med., 2017, 38(15), 95-95.
[15]
Barbosa, Jr F.; Sertorio, J.T.; Gerlach, R.F.; Tanus-Santos, J.E. Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch. Toxicol., 2006, 80(12), 811-816.
[16]
BORN. G.V.R. Aggregation of blood platelets byadenosine diphosphate and its reveasal. Nature, 1962, 194(4832), 927-929.
[17]
Guo, P.; Gu, W.X.; Chen, Q.X.; Lu, H.G.; Han, X.Q.; Li, W.; Gao, H. Dual functionalized amino poly (glycerol methacrylate) with guanidine and schiff-base linked imidazole for enhanced gene transfection and minimized cytotoxicity. J. Mater. Chem. B , 2015, 3(34), 6911-6918.
[18]
Liu, X.J.; Wang, C.Q.; Meng, J.; Shi, X.X.; Yan, Y.N.; Liu, X.G. Design, synthesis and biological evaluation of 4-methoxy diaryl isophthalates as antiplatelet agents. Med. Chem. Res., 2017, 1, 1-9.
[19]
Xu, S.Y.; Bian, R.L.; Chen, X. Pharmacological experimental methods, 2rd ed.; People’s medical Publishing House, Beijing. , 1991, pp. 14381-442.
[20]
Xiong, J.W.; Xiao, H.; Zhang, Z.X. An experimental research on different detection conditions between MTT and CCK-8. Acta. Laser. Biol. Sin., 2007, 16(5), 559-562.
[21]
Li, C.; Yang, Y.W.; Liang, Z.; Wu, G.; Gao, H. Post-modification of poly(glycidyl methacrylate)s with alkyl amine and isothiocyanate for effective pDNA delivery. Polym. Chem., 2013, 4(16), 4366-4374.
25
2
1
1